Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in biomarker sciences and technology
| Advances in biomarker sciences and technology |
| Pubbl/distr/stampa | Amsterdam : , : Elsevier B.V. on behalf of KeAi Communications Co. Ltd., , 2019- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2543-1064 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996411347303316 |
| Amsterdam : , : Elsevier B.V. on behalf of KeAi Communications Co. Ltd., , 2019- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Advances in biomarker sciences and technology
| Advances in biomarker sciences and technology |
| Pubbl/distr/stampa | Amsterdam : , : Elsevier B.V. on behalf of KeAi Communications Co. Ltd., , 2019- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2543-1064 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910447057903321 |
| Amsterdam : , : Elsevier B.V. on behalf of KeAi Communications Co. Ltd., , 2019- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 [[electronic resource] /] / edited by Paul C. Guest
| Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 [[electronic resource] /] / edited by Paul C. Guest |
| Autore | Guest Paul C |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (503 pages) |
| Disciplina | 614.5924144 |
| Collana | Proteomics, Metabolomics, Interactomics and Systems Biology |
| Soggetto topico |
Biochemical markers
Proteins Metabolism Genomics Biomarkers |
| ISBN | 3-031-28012-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology and Variants of Concern -- Chapter 2. Long-term Vaccination and Treatment Strategies for COVID-19 Disease and Future Coronavirus Pandemics -- Chapter 3. Consequences of the Lockdown - Domestic Violence during the COVID-19 Pandemic -- Chapter 4. Psychological distress impact of Coronavirus disease (COVID-19) outbreak on three continents: A systematic review and meta-analysis -- Chapter 5. A Molecular Biomarker-based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms -- Chapter 6. Genetic Associations with Coronavirus Susceptibility and Disease Severity -- Chapter 7. COVID Diagnostics: from Molecules to Omics -- Chapter 8. Assessing Biomarkers in Viral Infection -- Chapter 9. Proteomic Investigation of COVID-19 Severity During the Tsunamis Second Wave in Mumbai -- Chapter 10. NMR-Metabolomics in COVID-19 Research -- Chapter 11. Potential Biomarkers of Mitochondrial Dysfunction Associated with COVID-19 Infection -- Chapter 12. Red Cell Distribution Width as a Prognostic Indicator for Mortality and ICU Admission in Patients with COVID-19 -- Chapter 13. Predicting the COVID-19 Patients Status using Chest CT Scan Findings: A Risk Assessment Model Based on Decision Tree Analysis -- Chapter 14. Inferring Recombination Events in SARS-CoV-2 Variants In Silico -- Chapter 15. Amplicon-based Nanopore Sequencing of Patients Infected by the SARS-CoV-2 Omicron (B.1.1.529) Variant in India -- Chapter 16. Perspectives on Rapid Antigen Tests for Downstream Validation and Development of Theranostics -- Chapter 17. Machine Learning and COVID-19: Lessons from SARS-CoV-2 -- Chapter 18. The Relationship between Psoriasis, COVID-19 Infection and Vaccination during Treatment of Patients -- Chapter 19. Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study -- Chapter 20. Spices and Biomarkers of COVID-19: A Mechanistic and Therapeutic Perspective -- Chapter 21. Antiviral Mechanisms of Curcumin and its Derivatives in Prevention and Treatment of COVID-19: A review -- Chapter 22. Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial -- Chapter 23. Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases of COVID-19: A Hypothetical Approach -- Chapter 24. The Potential Effect of Royal Jelly on Biomarkers Related to COVID-19 Infection and Severe Progression -- Chapter 25. Statins: Beneficial Effects in Treatment of COVID-19 -- Chapter 26. Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease -- Chapter 27. Rapid Detection of SARS-CoV-2 Variants of Concern by Genomic Surveillance Techniques. |
| Record Nr. | UNINA-9910736994103321 |
Guest Paul C
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarker insights
| Biomarker insights |
| Pubbl/distr/stampa | Auckland, N.Z., : Libertas Academica Ltd |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers Biological Markers |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996207431003316 |
| Auckland, N.Z., : Libertas Academica Ltd | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Biomarker insights
| Biomarker insights |
| Pubbl/distr/stampa | Auckland, N.Z., : Libertas Academica Ltd |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers Biological Markers |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910144172703321 |
| Auckland, N.Z., : Libertas Academica Ltd | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarker research
| Biomarker research |
| Pubbl/distr/stampa | London, : BioMed Central, 2013- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers |
| Soggetto genere / forma |
Periodicals.
Fulltext Internet Resources. Periodical |
| Soggetto non controllato | Genetics |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996200686803316 |
| London, : BioMed Central, 2013- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Biomarker research
| Biomarker research |
| Pubbl/distr/stampa | London, : BioMed Central, 2013- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemical markers
Biomarkers |
| Soggetto genere / forma |
Periodicals.
Fulltext Internet Resources. Periodical |
| Soggetto non controllato | Genetics |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910141525203321 |
| London, : BioMed Central, 2013- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers and genomic medicine
| Biomarkers and genomic medicine |
| Pubbl/distr/stampa | [Taiwan] : , : Elsevier Taiwan LLC, , 2013- |
| Descrizione fisica | 1 online resource |
| Disciplina | 576.5 |
| Soggetto topico |
Genomics
Biochemical markers Medicine Biomarkers Genòmica Marcadors bioquímics |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| Soggetto non controllato | Genetics |
| ISSN | 2214-0255 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | BGM |
| Record Nr. | UNISA-996210410103316 |
| [Taiwan] : , : Elsevier Taiwan LLC, , 2013- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Biomarkers and genomic medicine
| Biomarkers and genomic medicine |
| Pubbl/distr/stampa | [Taiwan] : , : Elsevier Taiwan LLC, , 2013- |
| Descrizione fisica | 1 online resource |
| Disciplina | 576.5 |
| Soggetto topico |
Genomics
Biochemical markers Medicine Biomarkers Genòmica Marcadors bioquímics |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| Soggetto non controllato | Genetics |
| ISSN | 2214-0255 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | BGM |
| Record Nr. | UNINA-9910333112903321 |
| [Taiwan] : , : Elsevier Taiwan LLC, , 2013- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun
| Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun |
| Autore | Atukeren Pınar |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] |
| Descrizione fisica | 1 online resource (739 pages) |
| Disciplina | 610.28 |
| Soggetto topico |
Biomedical engineering
Radiology Biomarkers Biomarkers, Tumor |
| Soggetto non controllato |
Biochemical Markers
Clinical Biochemistry Science Medical |
| ISBN | 981-5040-46-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- New Biomarkers and Immunotherapy Decision -- Abdurrahman Yigit1, Berkay Kuscu2, Ali Kirik2, Ruhsen Ozcaglayan2 and Cigdem Usul Afsar3,* -- NEW BIOMARKERS AND IMMUNOTHERAPY DECISION -- Principles of Cancer İmmunotherapy -- Tumor Immunology -- Therapeutic Approaches -- Immune Checkpoint Inhibitors (ICI) -- THE PREDICTIVE AND PROGNOSTIC MARKERS OF IMMUNOTHERAPY -- Immunotherapy Toxicity -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Gynecologic Tumors -- Selim Afsar1,* -- INTRODUCTION -- Ovarian and Fallopian Tube Cancers -- Carbohydrate Antigen 125 (CA125) -- Screening -- Prediction Models -- Prognosis -- Recurrence -- Human Epididymis Protein 4 (HE4) -- Diagnosis -- Prognosis -- Risk of Ovarian Malignancy Algorithm (ROMA) -- Circulating Cell-Free DNA (cfDNA) -- DNA Methylation -- Metabolites -- MicroRNAs -- Carcinoembryonic Antigen (CEA) -- Alpha-Fetoprotein (AFP) -- Inhibin B -- Human Chorionic Gonadotropin (hCG) -- Kallikreins -- Other Markers -- Uterine Cancer -- CA125 -- HE4 -- Genomic Classification -- Other Markers -- Cervical Cancer -- Squamous Cell Carcinoma Antigen (SCC-Ag) -- Other Markers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Urological Cancers -- Bulent Onal1,*, Mehmet Hamza Gultekin1, Muhammed Fatih Simsekoglu1, Berin Selcuk1 and Ahmet Gurbuz1 -- BIOMARKERS IN BLADDER CANCER -- Blood-based Biomarkers -- Tumor Cells -- CD8 Count and Immune Cells -- Matrix Metalloproteinase -- Epigenetic Markers -- Tissue-based Biomarkers -- Cell Cycle-based Markers -- Transmembrane- and Signaling-based Markers -- PDL/PDL1 -- mTOR -- MDR1 -- Human Epidermal Growth Factor Receptor 2 (HER2).
Apoptosis- and DNA Repair-Based Markers -- Multiplexed Markers -- Twenty-Gene Panel, GenomeDX Gene-Expression Assay -- Urine-based Biomarkers -- Fluorescence In situ Hybridization (FISH) -- Bladder Tumor Antigen (BTA) Tests -- Nuclear Matrix Protein-22 (NMP-22) Test -- ImmunoCyt Test -- CxBladder Test -- SUMMARY -- BIOMARKERS IN PROSTATE CANCER -- Blood-Based Biomarkers -- PSA or hK3 -- Free PSA (fPSA) -- Prostate Health Index (PHI) -- 4Kscore Test -- Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) -- Prostate-Specific Membrane Antigen (PSMA) -- Urine-Based Biomarkers -- PCA3 -- Gene Fusion -- SelectMDx -- Annexin A3 -- Tissue-Based Biomarkers -- α-Methylacyl Coenzyme A Racemase (AMACR) -- Epigenetic Modifications -- Genomic Expression Profiles -- Inherited Genetic Markers -- SUMMARY -- BIOMARKERS IN RENAL CELL CARCINOMA -- Diagnostic Biomarkers -- Carbonic Anhydrase IX (CAIX) -- Gene Expression Profile -- Urine Biomarkers -- Tissue Biomarkers -- Prognostic Biomarkers -- Routine Blood Biomarkers -- Von Hippel-Lindau (VHL) Gene -- VEGF -- Survivin -- p53 -- Ki-67 -- Phosphatase and Tensin Homolog (PTEN) -- Predictive Biomarkers -- Immune Checkpoint Inhibitors -- mTOR Inhibitors -- Pediatric Renal Tumors: -- SUMMARY -- BIOMARKERS IN TESTICULAR CANCER -- Alfa-fetoprotein (AFP) -- Human Chorionic Gonodotropin (HCG) -- Lactate Dehydrogenase (LDH) -- Potential Biomarkers in Future -- Placental Alkaline Phosphatase (PLAP) -- Oct-3/4, Sall 4, and CD 117 -- miRNAs -- SUMMARY -- NEXT GENERATION SEQUENCING -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Thyroid Cancer -- Lebriz Uslu-Beşli1,* -- INTRODUCTION -- THYROID GLAND -- CLASSIFICATION OF THYROID CANCER -- MEDICAL MANAGEMENT OF THYROID CANCER -- Differentiated Thyroid Cancer -- Medullary Thyroid Cancer. Anaplastic Thyroid Cancer -- SEROLOGICAL BIOMARKERS -- Thyroglobulin -- Anti-thyroglobulin Antibodies -- Calcitonin and Procalcitonin -- Carcinoembryonic Antigen -- Other Peptides -- LIQUID BIOPSY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- DNA Methylation Biomarkers in Cancer: Current Clinical Utility and Future Perspectives -- Sinem Durmus1,*, Remise Gelisgen1 and Hafize Uzun2 -- INTRODUCTION -- DNA METHYLATION AND REGULATION MECHANISM -- DNA Methylation in Cancer -- Regional Hypermethylation -- Global Hypomethylation -- DNA Methylation Biomarkers in Cancer -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Predicting Pathological Response to Neoadjuvant Therapy for Colorectal Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Tissue Based Biomarkers -- DNA Alterations: Polymorphisms -- Gene Expression -- MicroRNA (miRNA) -- Blood Based Biomarkers -- cfDNA and ctDNA -- cfmRNA and hTERT -- cfmiRNA -- CIRCULATING PROTEINS/PEPTIDES -- OTHER PREDICTIVE BIOMARKERS -- Thymidylate Synthase (TS) -- Epidermal Growth Factor Receptor (EGFR) -- Cyclooxygenase 2 (COX-2) -- Bax/bcl-2 -- P21 -- Ki-67 -- CEA -- ctDNA -- Circulating Tumour Cells (CTC) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERANCES -- Circulating Biomarkers in the Management of Breast Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Carcinoembryonic Antigen (CEA) -- MUC-1 -- HER-2 -- Cytokeratins (CK) -- Specific Classes of Circulatory Biomarkers -- Proteins -- Autoantibodies -- Circulating Tumour Cells (CTC) -- Exosomes -- MicroRNA (miRNA) -- Circulating Cell-Free DNA (cfDNA). BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF BREAST CANCER -- MONITORING RESPONSE TO THERAPY AND SURVEILLANCE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Clinical Application of Biomarkers for Hematologic Malignancies -- Nurgül Özgür Yurttaş1 and Ahmet Emre Eşkazan1,* -- INTRODUCTION -- BIOMARKERS IN MYELOID NEOPLASMS -- Acute Myeloid Leukemia -- CYTOGENETIC CLASSIFICATION OF AML -- MRD IN AML -- Myelodysplastic Syndrome -- CHROMOSOMAL ABNORMALITIES IN MDS -- Deletions of Chromosome 5 -- Monosomy 7 and Deletions of Chromosome 7 -- Diagnosis and Classification -- 5q-syndrome/MDS with an Isolated del(5q) -- Role of Cytogenetics in the Prognosis of MDS -- GENETIC MUTATIONS IN MDS -- Myeloproliferative Neoplasms -- Mutations in PV, ET, and PMF -- BIOMARKERS IN CHRONIC MYELOID LEUKEMIA -- Prognostic Factors at the Time of Diagnosis -- Use of the Mutational Analysis in CML -- Identification of Molecular Markers of Progression -- BIOMARKERS IN LYMPHOID NEOPLASMS -- BIOMARKERS IN ACUTE LYMPHOBLASTIC LEUKEMIA/ LYMPHOMA -- CYTOGENETIC AND MOLECULAR ABNORMALITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA -- B-ALL/LBL with Recurrent Genetic Abnormalities -- T-ALL/LBL -- Cytogenetic Abnormalities in T-ALL/LBL -- Molecular Abnormalities in T-ALL/LBL -- EARLY T-CELL PRECURSOR ALL/LBL -- MRD IN ALL -- BIOMARKERS IN LYMPHOMAS -- Biomarkers of Genetic Changes -- B-Cell Lymphoma 6 (BCL6) -- Tumor Protein 53 (TP53) -- V-Myc Avian Myelocytomatosis Viral Oncogene Homolog (MYC) -- B-Cell Lymphoma 2 (BCL2) -- Myeloid Differentiation Primary Response 88 (MYD88) -- Other Genetic Biomarkers in B-Cell Lymphomas -- Other Genetic Biomarkers in Peripheral T-Cell Lymphoma (PTCL) -- Biomarkers Related to Epigenetic Changes -- Other Epigenetic Gene Features -- MicroRNA and LncRNA in Diagnosis and Prognosis of Lymphomas. Other MicroRNAs and MicroRNA-Based Classifiers -- Immunophenotypic Biomarkers -- CD30 -- Bcl-6, Bcl-2, and Myc -- Cyclin D1 and SOX-11 -- TP53 and MDM2 -- Immunophenotypic Biomarkers -- Immunohistochemical Biomarkers of Peripheral T-Cell Lymphoma -- Microenvironment-related Biomarkers for Prognosis and Immunotherapy -- BIOMARKERS IN MULTIPLE MYELOMA -- STAGING SYSTEMS -- GENOMIC BIOMARKERS -- Gene Expression Profiling -- NOVEL BIOMARKERS -- Minimal Residual Disease -- Next-Generation Biomarkers in MM -- Immunotherapy-related Biomarkers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Applications of Biomarkers in Cancer Surgery -- Berrin Papila Kundaktepe1,* -- INTRODUCTION -- CIRCULATING TUMOR MARKERS: CLINICAL APPLICATIONS -- Applications Of Tumor Markers In Colorectal Cancer -- Applications of Tumor Markers in Hepatocellular Carcinoma (HCC) -- Applications of Tumor Markers in Pancreatic Adenocarcinoma -- Applications of Tumor Markers In Breast Cancer -- Circulating Tumor Cells -- ENDOCRINE TUMOR MARKERS -- Immunohistochemical and Circulating Tumor Markers of NETs -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- A Pathophysiological Approach To Current Biomarkers -- Aykut Oruc1,* and Gonul Simsek1 -- CARDIAC BIOMARKERS -- Cardiac Troponins -- Troponin Subunits -- Regulatory Function of Troponin -- Cardiac Troponins as a Biomarker for Acute Myocardial Infarction: The Pathophysiology -- Cardiac Troponins as a Biomarker in Congestive Heart Failure -- Heart-Type Fatty Acid Binding Protein -- Heart-Type Fatty Acid Binding Protein in Acute Myocardial Ischemia -- Glycogen Phosphorylase Isoenzyme BB -- Myocardial Oxygen Deficiency and GPBB Release: The Pathophysiology -- Glutathione S-Transferase P1 -- N-Terminal pro-Brain Natriuretic Peptide. Pathophysiological Mechanisms in Synthesis and Secretion of BNP and NT-proBNP. |
| Record Nr. | UNINA-9910795982603321 |
|
Atukeren Pınar
|
||
| Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Biomarkers
(39)
- Biochemical markers (31)
- Biological Markers (6)
- Genomics (5)
- Medicine (4)